Figure 4From: Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines IC 50 obtained from single agent response curves for gemcitabine and docetaxel was compared to the IC 50 obtained after adding dasatinib at a minimally active concentration (IC 25 ). Graphics above represents the results of a single experiment for SK-UT-1 (A & B) and SK-UT-1B (C & D). (Gem = gemcitabine; Das = dasatinib; Doc = docetaxel).Back to article page